Edwards Lifesciences Q3 Revenue $1.48B vs $1.479B Est.
Portfolio Pulse from Benzinga Newsdesk
Edwards Lifesciences reported Q3 revenue of $1.48B, slightly above the estimated $1.479B.
October 25, 2023 | 8:22 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Edwards Lifesciences' Q3 revenue slightly exceeded estimates, which could positively impact the stock.
Edwards Lifesciences' Q3 revenue beat estimates, which is generally seen as a positive sign by investors and could lead to an increase in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100